|
Issue
Number 9 – Unusual Cases
This issue is devoted to a discussion of the unusual forms of prostate cancer
Dr Myers finds in his practice or the medical literature. Topics include: extensive
hormone refractory cancer in the pelvis without distant metastatic disease; advanced
prostate cancer with only lymph node involvement; extensive metastatic disease
with PSA less than 10 ng/ml; and neuroendocrine carcinoma of the prostate gland. |
 |
|
Issue
Number 8 – Surgery for High Risk Disease
Dr. Myers discusses using surgery to treat high risk prostate cancer. In a subsequent
article, he discusses oligometastatic disease, or a prostate cancer that has
few metastatic
lesions. |
|
|
Issue Number
7 – Vitamin D3 & Slow
Growing Recurrent Prostate Cancer
Dr. Snuffy Myers discusses the possibilities of treating PSA-only recurrences
after surgery or radiation treatment with Vitamin D3 (cholecalciferol). Other
possible agents for treating such recurrences include: Celebrex, Proscar/Avodart,
Leukine, Calcitriol, Avastin, the Mediterranean heart healthy diet, and pomegranate. |
|
|
Issue
Number 6 – Radiation Therapy &
High-Risk Prostate Cancer
Michael Dattoli's 2007 Cancer Study has had an impact on how we view radiation
therapy for high-risk prostate cancer. In this issue of Prostate Forum Dr. Myers
discusses Dattoli’s findings and its implications for treatment. |
|
|
Issue Number
5 – Process of Cancer
Spread & Testosterone Replacement
In this issue Dr Myers discusses how prostate cancer spreads throughout the body.
In a subsequent article, he analyses the pros and cons of testosterone replacement
therapy. |
|
|
Issue Number
4 – Nutrition Revisited,
Part II
In this issue of Prostate Forum, Dr. Snuffy Myers analyses recent clinical trials
on nutrition and prostate cancer with a focus on selenium, flaxseed, red wine
and lycopene. |
|
|
Issue Number
3 – Nutrition Revisited,
Part I
Every day we’re bombarded with news stories about the latest scientific
studies on prostate cancer. But how do you know if a study was well done and
its results worth paying attention to? In this issue of Prostate Forum, we offer
some guidelines and insights into how to best evaluate the latest scientific
studies on prostate cancer. |
|
|
Issue Number
2 – Emergent Trends
This issue offers some final thoughts on the FDA's decision about provenge as
well as in-depth discussions of the new warning about Zometa and heart damage;
how grilling, frying or roasting meat may affect prostate cancer; whether or
not soy increases the risk of advanced disease; regaining erections after surgery,
radiation or hormonal therapy; and how to deal with a troublesome (and painful)
treatment side effect. |
|
|
Issue Number
1 – Provenge
We now have a robust understanding of how the immune system can act to control
cancer progression. We have vaccine strategies that work very well in animal
models. There are multiple cancer vaccines in clinical trial for prostate cancer
and others malignancies. At the end of March, one of these vaccines for prostate
cancer, Provenge, went before the FDA advisory committee and may well attain
final approval in May. In this article, we will explain how this vaccine works
and why it has faced controversy during the approval process. |
|
| Please select a delivery method: |
|
I would like to receive a PDF (download Adobe
Acrobat Reader) |
|
I would like to receive a hard copy via regular mail |
|
|
